1. Home
  2. TKLF vs LGVN Comparison

TKLF vs LGVN Comparison

Compare TKLF & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yoshitsu Co. Ltd

TKLF

Yoshitsu Co. Ltd

HOLD

Current Price

$2.08

Market Cap

10.1M

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$1.12

Market Cap

11.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKLF
LGVN
Founded
2006
2014
Country
Japan
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
11.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
TKLF
LGVN
Price
$2.08
$1.12
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
15.4K
8.5M
Earning Date
12-19-2025
03-17-2026
Dividend Yield
11.13%
N/A
EPS Growth
N/A
50.76
EPS
N/A
N/A
Revenue
N/A
$709,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,183.95
P/E Ratio
$2.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$0.48
52 Week High
$4.32
$1.83

Technical Indicators

Market Signals
Indicator
TKLF
LGVN
Relative Strength Index (RSI) 32.36 66.90
Support Level $2.10 $0.55
Resistance Level $3.09 $1.22
Average True Range (ATR) 0.15 0.14
MACD -0.03 0.01
Stochastic Oscillator 11.30 78.24

Price Performance

Historical Comparison
TKLF
LGVN

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: